Interview with Yves Groult, Managing Director, Boiron Hungary
Hungary has one of the oldest drug industries in Europe, but homeopathy too has quite a history in the country, with the Homoeopathic Doctor’s Association being founded as early as…
Address: Ady Endre Ut 8 H-1024 Budapest,Hungary
Tel: +36 1 365 1430
Company allapillére way back to health with concrete ideas. More than 50 countries throughout the world for thousands of people’s determination and dedication mean performance is key.
French company, we are szakterületünkön, the world leader in homeopathic medicines. In France, four manufacturing sites and 32 industrial preparation and marketing of a need.
The company – like other companies – currently live in troubled times, but we are confident that it can bring positive changes in the long run, especially in medicine, but the pharmaceutical industry and health care management field.
As a family company we make every effort to adapt to the industry’s difficulties. Humbly, but we try to give you a chance gyógyszereinknek determination, to show their usefulness and efficiency. The French pharmaceutical market is less than 1% of you have … this shows how much we have the opportunity to grow!
A homeopathic preparation of a mono (rarely more) ingredients. The raw material of plant, mineral and animal origin can be.
The Latin name of the homeopathic remedies, the main raw material used to manufacture internationally known scientific names. The Latin name is due to the international homeopathic medicines in all countries of the same name.
The number on the tube dilution őstinktúra your area. The initials represent the type of dilution (C = one hundred times (centezimális) dilution, H = Hahnemann method of preparation)
The mono homeopathic preparations usually used several times in tubes or pellets számlálós-dose disposable containers, and sometimes liquid droplets (or őstinktúra homeopathic dilution) in the form can be purchased. The pharmaceutical industry is also found in other forms of production in homeopathy, but expect much less widespread.
Hungary has one of the oldest drug industries in Europe, but homeopathy too has quite a history in the country, with the Homoeopathic Doctor’s Association being founded as early as…
MD Pál Szamosújvari, Judit Jávor, Pál Szamosújvari Jr—Founder, R&D Director, and Director of Pharma Patent respectively—share their insights on the activities of the company, the importance of R&D, the challenges…
Csilla Léka, general manager of Global Clinical Trials in Hungary shares her insights on the portfolio of the company, the most prevalent therapeutic areas, the developments in clinical trials over…
Calin Galaseanu, recently appointed general manager of Novo Nordisk Hungary, elaborates on the country’s strong treatment paradigm for diabetes. He goes on to highlight Hungary’s key positioning as a strategic…
László Dene, managing director of Bellis, gives his insights on the trends affecting the wholesale supply chain and product delivery in Hungary, the strategic positioning of the company as the…
Gergely Jánoki CEO of Medi-Radiopharma shares his insights on the activities of the company, the trends in the radiopharmaceutical industry while highlighting regulatory trends, the importance of quality, the driving…
Dr Antal Feller, CEO of Hungaropharma, gives his insights on the pharma trends affecting the wholesale supply chain and product delivery in Hungary, the strategic positioning of the company, on…
Francesco Banchi, general manager of Boehringer Ingelheim Hungary, elaborates on the successful development of the affiliate in recent years, making progress in new product reimbursement. As an experienced leader in…
Dr. Bodoky Gyorgy, founder and Honorary President of the Hungarian Society of Clinical Oncology (MKOT), explains the activities of the society, the multi-stakeholder collaborations MKOT has, the challenges of oncological…
Péter Ferdinandy and Zsuzsanna Helyes, President and Secretary General of the Hungarian Society for Experimental and Clinical Pharmacology (HUPHAR), share their insights about the role of the society, the R&D…
József Béres, President of Béres and Ferenc Major, CEO, share their insights on the history of the company, its performance and approach to creating brand awareness, the importance of R&D…
Dr. András Szabó, CEO of Szinapszis, a Hungarian market research and consulting agency specialized in the health industry, offers his expert insights on the key challenges and trends shaping the…
After years of planning and collaboration with various stakeholders, in 2017 the Hungarian government launched the Electronic Health Service Area (EESZT): a centralized database of patient records and health interventions…
See our Cookie Privacy Policy Here